Baseline LDH as a prognostic biomarker of early treatment failure in lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers ...

Novel Graph Neural Network (N-GNN) Model Achieves Superior Accuracy in Early Lung Cancer Detection, Paving the Way for Enhanced Diagnostic Capabilities. The research, a collaboration between BioMark's ...

Lung cancer screening in high-risk never-smokers with artificial intelligence (LC-SHIELD study). Hypofraction radiotherapy followed by immune checkpoint inhibitors for locally advanced non-small cell ...

A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including very small nodules that are often difficult to ...

【Backgrounds】 In 2015, the First Affiliated Hospital of Guangzhou Medical University, in collaboration with the Guangdong Hetaoxiang Medical Charity Foundation and the Guangzhou Charity Association, ...

Make this your preferred source to get more updates from this publisher on Google. Higher mortality rates due to lung cancer may be avoided if there is increased early detection of the disease, ...

Lung cancer is one of the major causes of cancer-related fatalities in the global society, particularly due to its late diagnosis in most cases. Early diagnosis has great benefits in terms of survival ...